- Home
- IOVA vs PHK Comparison
IOVA vs PHK Comparison
Compare IOVA & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- PHK
- Stock Information
- Founded
- IOVA 2007
- PHK 2003
- Country
- IOVA United States
- PHK United States
- Employees
- IOVA N/A
- PHK N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- PHK Finance/Investors Services
- Sector
- IOVA Health Care
- PHK Finance
- Exchange
- IOVA Nasdaq
- PHK Nasdaq
- Market Cap
- IOVA 771.4M
- PHK 769.6M
- IPO Year
- IOVA N/A
- PHK N/A
- Fundamental
- Price
- IOVA $1.98
- PHK $4.76
- Analyst Decision
- IOVA Buy
- PHK
- Analyst Count
- IOVA 10
- PHK 0
- Target Price
- IOVA $12.22
- PHK N/A
- AVG Volume (30 Days)
- IOVA 11.2M
- PHK 491.5K
- Earning Date
- IOVA 08-07-2025
- PHK 01-01-0001
- Dividend Yield
- IOVA N/A
- PHK 12.61%
- EPS Growth
- IOVA N/A
- PHK N/A
- EPS
- IOVA N/A
- PHK N/A
- Revenue
- IOVA $212,679,000.00
- PHK N/A
- Revenue This Year
- IOVA $86.62
- PHK N/A
- Revenue Next Year
- IOVA $69.95
- PHK N/A
- P/E Ratio
- IOVA N/A
- PHK N/A
- Revenue Growth
- IOVA 11070.12
- PHK N/A
- 52 Week Low
- IOVA $1.64
- PHK $4.13
- 52 Week High
- IOVA $12.51
- PHK $5.15
- Technical
- Relative Strength Index (RSI)
- IOVA 43.44
- PHK 47.25
- Support Level
- IOVA $1.95
- PHK $4.72
- Resistance Level
- IOVA $2.47
- PHK $4.78
- Average True Range (ATR)
- IOVA 0.15
- PHK 0.03
- MACD
- IOVA 0.05
- PHK -0.01
- Stochastic Oscillator
- IOVA 35.53
- PHK 35.00
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.